Alpha calculus in clinical trials: Considerations and commentary for the new millennium

Statistics in Medicine

Volumn 19, Issue 6, 2000, Pages 767-779

  Moyé, Lemuel A ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; CLINICAL TRIAL; EXPERIMENT; HYPOTHESIS; MEDICINE; NOMENCLATURE; REVIEW; SAMPLING; STANDARD; SYSTEM ANALYSIS; THEORY;

EID: 0343673950     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(20000330)19:6<767::AID-SIM518>3.0.CO;2-U     Document Type: Review

References (26)

1. Simes RJ. An improved Bonferroni procedure for multiple tests of significance. Biometrika 1986; 73: 751-754.
2. Worsley KL. An improved Bonferroni inequality and applications. Biometrika 1982; 69: 297-302.
3. Pocock SJ, Geller NL, Tsiasis AA. The analysis of multiple endpoints in clinical trials. Biometrics 1987; 423: 487-498.
4. Friedman L, Furberg C, DeMets D. Fundamentals of Clinical Trials, 3rd edn. Mosby, 1996; 308.
5. Fisher L. Carvedilol and the FDA approval process: the FDA paradigm and reflections upon hypothesis testing. Controlled Clinical Trials. 1999; 20: 16-39.
6. Moyé LA. P-value interpretation in clinical trials. The case for discipline. Controlled Clinical Trials. 1999; 20: 40-49.
7. Rothman RJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46.
8. Moyé LA. P-value interpretation and alpha allocation in clinical trials. Annals of Epidemiology 1998; 8: 351-357.
9. Pfeffer MA, Braunwald, E, Moyé LA et al. Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction - results of the Survival and Ventricular Enlargement Trial. New England Journal of Medicine 1992; 327(10): 669-677.
10. Sacks FM, Pfeffer MA, Moyé LA. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine 1996; 335: 1001-9.
11. The SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug therapy in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 1991; 265(24).
12. Mahmarian JJ, Moyé LA, Chinoy DA, Sequeira RF, Habib GB, Henry WJ, Jain A, Chaitman BR, Weng CSW, Morales-Ballejo H, Pratt CM. Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized double-blind placebo controlled trial. Circulation 1998; 97: 2017-2024.
13. The Lipid Research Clinics Coronary Primary Prevention trial results. Journal of the Americal Meedical Association 1984; 251: 351-374.
14. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecanide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 321: 227-233.
15. Linet MS, Hatch EE, Lkeinerman RA, Robison LL, Kaune WT, Freidman DR, Severson RK, Haines CM, Hartsock CT, Niwa S, Wacholder S, Tarone RE. Residental Exposure to Magnetic Fields and acute lymphoblastic leukemia in children. New England Journal of Medicine 1997; 2337: 1-7.
16. Hayes DL, Wanbg PJ, Reynolds DW, Estes M, Griffith JL, Steffens RA, Carlo GL, Findlay GK, Johnson CM. Interference with cardiac pacemakers by cellular telephones. New England Journal of Medicine 1997; 36: 1473-1479.
17. Miller, RG. Simultaneous Statistical Inference. : Springer-Verlag: New York, 1981.
18. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079-1087.
19. Gibbons JD, Pratt JW. P-values:interpretation and methodology. American Statistician 1975; 29(1): 20-25.
20. Dubey SD. Adjustment of p-values for multiplicities of interconnecting symptoms. In Statistics in the Pharmaceutical Industry, 2nd edn, Buncher RC, and Tsay JY (eds). Marcel Dekkert Inc.: New York, 1994; 513-527.
21. Westfall PH, Young S. p-value adjustments for mulitple tests in multivariate binomial models. Journal of the Americal Statistical Association. 1989; 84: 780-786.
22. Lan KKG, Demets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-663.
23. Lan KKG, Simon R, Halperin M. Stochastically curtailed tests in long-term clinical trials. Communications in Statistics 1982;
24. Davis BR, Hardy RJ. Upper bounds for type I and type II error rates in conditional power calculations. Communications in Statistics 1990; 19(10): 3571-3584.
25. Lan KKG, Wittes J. The b-value: a tool for monitoring data. Biometrics 1988; 44: 579-585.
26. Westfall PH, Krishnen A, Young SS. Using prior information to allocate significance levels for multiple endpoints. Statistics in Medicine 1998; 17: 2107-2119.